Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data.
Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data. Clin Cancer Res. 2026 Jan 16; 32(2):428-437.
PMID: 41213110
K-means clustering-based analysis of quantitative ultrafast DCE-MRI for predicting breast cancer response to neoadjuvant chemotherapy.
K-means clustering-based analysis of quantitative ultrafast DCE-MRI for predicting breast cancer response to neoadjuvant chemotherapy. J Appl Clin Med Phys. 2026 Jan; 27(1):e70439.
PMID: 41456332
Adjuvant Chemotherapy Use for Hormone Receptor-Positive, ERBB2-Negative Breast Cancer After RxPONDER Trial.
Adjuvant Chemotherapy Use for Hormone Receptor-Positive, ERBB2-Negative Breast Cancer After RxPONDER Trial. JAMA Netw Open. 2025 Dec 01; 8(12):e2549109.
PMID: 41632146
Virtual multiplex immunofluorescence identifies lymphocyte subsets predictive of response to neoadjuvant therapy.
Virtual multiplex immunofluorescence identifies lymphocyte subsets predictive of response to neoadjuvant therapy. Ther Adv Med Oncol. 2025; 17:17588359251379411.
PMID: 41142474
Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/HER2-negative breast cancer.
Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/HER2-negative breast cancer. Ann Oncol. 2025 Nov; 36(11):1356-1365.
PMID: 40972946
Rethinking Treatment Priorities in Estrogen Receptor-Low Breast Cancer.
Rethinking Treatment Priorities in Estrogen Receptor-Low Breast Cancer. J Clin Oncol. 2025 Oct 20; 43(30):3322-3323.
PMID: 40875954
Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer.
Integration of Gene Expression and Digital Histology to Predict Treatment-Specific Responses in Breast Cancer. medRxiv. 2025 Aug 27.
PMID: 40909848
Building digital histology models of transcriptional tumor programs with generative deep learning for pathology-based precision medicine.
Building digital histology models of transcriptional tumor programs with generative deep learning for pathology-based precision medicine. Genome Med. 2025 Aug 07; 17(1):87.
PMID: 40775734
Corrigendum to "Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas". [Oral Oncol. 163 (2025) 107207].
Corrigendum to "Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas". [Oral Oncol. 163 (2025) 107207]. Oral Oncol. 2025 Oct; 169:107510.
PMID: 40721367
Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy Benefit.
Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy Benefit. medRxiv. 2025 May 16.
PMID: 40661301